Researcher profile
Thomas Hankemeier
Public evidence
12 connected articles
Metabolic alteration in oxylipins and endocannabinoids point to an important role for soluble epoxide hydrolase and inflammation in Alzheimer's disease-finding from Alzheimer's Disease Neuroimaging Initiative.2026 · Europe PMCThe role of dopaminergic medication and specific pathway alterations in idiopathic and <i>PRKN/PINK1</i>-mediated Parkinson's disease.2025 · Europe PMCStrategies for Using Postcolumn Infusion of Standards to Correct for Matrix Effect in LC-MS-Based Quantitative Metabolomics.2024 · Europe PMCAcute and long-term exercise differently modulate plasma levels of oxylipins, endocannabinoids, and their analogues in young sedentary adults: A sub-study and secondary analyses from the ACTIBATE randomized controlled-trial.2022 · Europe PMCPlasma Levels of Endocannabinoids and Their Analogues Are Related to Specific Fecal Bacterial Genera in Young Adults: Role in Gut Barrier Integrity.2022 · Europe PMCThe contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.2021 · Europe PMCSignaling lipids as diagnostic biomarkers for ocular surface cicatrizing conjunctivitis.2020 · Europe PMCIdentification of α,β-Hydrolase Domain Containing Protein 6 as a Diacylglycerol Lipase in Neuro-2a Cells.2019 · Europe PMCHigh Fat Diet Increases Circulating Endocannabinoids Accompanied by Increased Synthesis Enzymes in Adipose Tissue.2018 · Europe PMCCaloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes.2018 · Europe PMCEndocannabinoid tone is higher in healthy lean South Asian than white Caucasian men.2017 · Europe PMCLipidomics reveals multiple pathway effects of a multi-components preparation on lipid biochemistry in ApoE*3Leiden.CETP mice.2012 · Europe PMC
Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.